| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $250,000 | 1 | 14 |
Sells | $591,850 | 6 | 86 |
| SIEGALL CLAY B | director | 1 | $250,000 | 0 | $0 | $250,000 |
| Shukla Abhinav A. | Chief Technical Officer | 0 | $0 | 4 | $183,250 | $-183,250 |
| Pandite Arundathy N. | Chief Medical Officer | 0 | $0 | 2 | $408,600 | $-408,600 |
Shattuck Labs, Inc. operates as a biotechnology firm based in the United States, currently at the clinical development stage. Its core mission is to create innovative therapeutics designed to combat both cancer and autoimmune diseases. The company's leading experimental compound, SL-172154, is presently undergoing Phase 1 clinical assessment for the treatment of ovarian, fallopian tube, and peritoneal cancers. Furthermore, Shattuck Labs is advancing another product candidate, SL-279252, which is also in Phase 1 trials for patients afflicted …
Over the last 12 months, insiders at Shattuck Labs, Inc. have bought $250,000 and sold $591,850 worth of Shattuck Labs, Inc. stock.
On average, over the past 5 years, insiders at Shattuck Labs, Inc. have bought $2.94M and sold $376,040 worth of stock each year.
Highest buying activity among insiders over the last 12 months: SIEGALL CLAY B (director) — $250,000.
The last purchase of 62,500 shares for transaction amount of $250,000 was made by SIEGALL CLAY B (director) on 2026‑06‑09.
| 2026-07-02 | Sale | Shukla Abhinav A. | Chief Technical Officer | 410 0.0009% | $7.01 | $2,874 | -4.04% | |
| 2026-07-01 | Sale | Shukla Abhinav A. | Chief Technical Officer | 100 0.0002% | $7.07 | $707 | +3.99% | |
| 2026-06-30 | Sale | Pandite Arundathy N. | Chief Medical Officer | 30,000 0.0633% | $7.01 | $210,300 | -2.52% | |
| 2026-06-30 | Sale | Shukla Abhinav A. | Chief Technical Officer | 23,365 0.0498% | $7.08 | $165,424 | -2.52% | |
| 2026-06-09 | SIEGALL CLAY B | director | 62,500 0.1222% | $4.00 | $250,000 | +52.34% | ||
| 2026-05-12 | Sale | Pandite Arundathy N. | Chief Medical Officer | 30,000 0.0625% | $6.61 | $198,300 | -4.38% | |
| 2026-05-12 | Sale | Shukla Abhinav A. | Chief Technical Officer | 2,032 0.0045% | $7.01 | $14,244 | -4.38% | |
| 2025-08-25 | ORBIMED ADVISORS LLC | director | 6.31M 11.8986% | $0.87 | $5.47M | +338.76% | ||
| 2025-08-25 | Ashiya Mona | director | 6.31M 11.8986% | $0.87 | $5.47M | +338.76% | ||
| 2024-12-04 | Sale | Redmile Group, LLC | 133,371 0.2728% | $1.25 | $166,714 | -7.20% | ||
| 2024-12-04 | Redmile Group, LLC | 133,371 0.2728% | $1.25 | $166,714 | -7.20% | |||
| 2024-10-07 | Schreiber Taylor | Chief Executive Officer | 36,500 0.0249% | $1.21 | $44,220 | +0.89% | ||
| 2024-06-28 | Brous Tyler | director | 3,000 0.0065% | $3.90 | $11,700 | -68.13% | ||
| 2024-06-27 | Brous Tyler | director | 5,416 0.0117% | $3.89 | $21,068 | -67.20% | ||
| 2024-06-26 | Schreiber Taylor | Chief Executive Officer | 14,400 0.0278% | $3.47 | $50,011 | -67.55% | ||
| 2024-03-06 | Sale | Stout Stephen | See Remarks | 11,354 0.0266% | $10.53 | $119,558 | -63.09% | |
| 2024-01-10 | Sale | Neill Andrew R | Chief Financial Officer | 25,000 0.0527% | $10.00 | $250,000 | -59.86% | |
| 2022-04-26 | Golumbeski George | 28,330 0.0665% | $3.63 | $102,838 | -16.16% | |||
| 2022-04-21 | Golumbeski George | 26,049 0.0621% | $3.69 | $96,121 | -15.89% | |||
| 2022-01-19 | Brous Tyler | director | 3,000 0.0073% | $6.87 | $20,610 | -48.05% |
| SIEGALL CLAY B | director | 318608 0.3175% | $1.74M | 1 | 0 | |
| Redmile Group, LLC | 5539724 5.5197% | $30.3M | 2 | 1 | +21.24% | |
| ORBIMED ADVISORS LLC | director | 5255106 5.2361% | $28.75M | 1 | 0 | +338.76% |
| Ashiya Mona | director | 5255106 5.2361% | $28.75M | 1 | 0 | +338.76% |
| Brous Tyler | director | 238088 0.2372% | $1.3M | 5 | 0 | <0.0001% |
| Schreiber Taylor | Chief Executive Officer | 71002 0.0707% | $388,380.94 | 2 | 10 | +0.89% |
| Golumbeski George | 54613 0.0544% | $298,733.11 | 2 | 0 | <0.0001% |
$10,154,205 | 103 | -4.60% | $631.34M | |
$40,226,318 | 58 | 18.89% | $539.26M | |
$16,169,789 | 40 | 7.44% | $485.1M | |
$1,344,238 | 38 | 23.07% | $639.18M | |
$8,866,498 | 28 | 33.64% | $474.26M |
| Increased Positions | 35 | +60.34% | 10M | +28.34% |
| Decreased Positions | 20 | -34.48% | 4M | -11.28% |
| New Positions | 16 | New | 8M | New |
| Sold Out Positions | 5 | Sold Out | 38,603 | Sold Out |
| Total Postitions | 73 | +25.86% | 42M | +17.06% |
| Orbimed Advisors Llc | $23,396.00 | 10.01% | 6.31M | +6M | New | 2025-09-30 |
| Adage Capital Partners Gp, L.L.C. | $23,396.00 | 10.01% | 6.31M | +2M | +34.89% | 2025-09-30 |
| Redmile Group, Llc | $20,552.00 | 8.79% | 5.54M | 0 | 0% | 2025-09-30 |
| Prosight Management, Lp | $20,224.00 | 8.65% | 5.45M | -1M | -17.89% | 2025-09-30 |
| Vanguard Group Inc | $7,896.00 | 3.38% | 2.13M | -19,773 | -0.92% | 2025-09-30 |
| 683 Capital Management, Llc | $5,685.00 | 2.43% | 1.53M | +437,216 | +39.93% | 2025-09-30 |
| Clark Estates Inc/Ny | $5,475.00 | 2.34% | 1.48M | 0 | 0% | 2025-09-30 |
| Pinnacle Associates Ltd | $5,152.00 | 2.2% | 1.39M | +25,000 | +1.83% | 2025-09-30 |
| Bank Of America Corp /De/ | $4,199.00 | 1.8% | 1.13M | +1M | +2,968.2% | 2025-09-30 |
| Millennium Management Llc | $2,563.00 | 1.1% | 690,901 | -152,355 | -18.07% | 2025-09-30 |